KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Asset Writedowns and Impairment (2016 - 2025)

Maxlinear (MXL) has disclosed Asset Writedowns and Impairment for 16 consecutive years, with $427000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 80.05% to $427000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $427000.0, a 93.02% decrease, with the full-year FY2025 number at $427000.0, down 92.31% from a year prior.
  • Asset Writedowns and Impairment was $427000.0 for Q4 2025 at Maxlinear, up from -$427000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.4 million in Q4 2023 to a low of -$427000.0 in Q3 2025.
  • A 5-year average of $920846.2 and a median of $462000.0 in 2022 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: skyrocketed 1269.0% in 2022, then plummeted 134.52% in 2025.
  • Maxlinear's Asset Writedowns and Impairment stood at -$200000.0 in 2021, then surged by 1269.0% to $2.3 million in 2022, then grew by 2.65% to $2.4 million in 2023, then fell by 10.83% to $2.1 million in 2024, then plummeted by 80.05% to $427000.0 in 2025.
  • Per Business Quant, the three most recent readings for MXL's Asset Writedowns and Impairment are $427000.0 (Q4 2025), -$427000.0 (Q3 2025), and $449000.0 (Q2 2025).